MedTrace Logo

Resection vs. Best Supportive Care for Hepatocellular Carcinoma (HCC) With Portal Venous Thrombus

NCT01600196 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2019-01-23

No results posted yet for this study

Summary

The purpose of this study is to evaluate the long-term efficacy and safety of surgical resection compared with best supportive care in patients with resectable hepatocellular carcinoma (HCC) with portal venous thrombus (PVTT) in the first branch of portal vein.

Conditions

  • Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Interventions

PROCEDURE

Liver resection plus Thrombectomy

Liver resection plus Thrombectomy

Sponsors & Collaborators

  • Guangzhou 8th People's Hospital

    collaborator OTHER

  • Kaiping Central Hospital

    collaborator OTHER

  • The 458 Hospital of Chinese People's Liberation Army

    collaborator UNKNOWN

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Ming Shi, MD. · Sun Yat-sen University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2009-07-31
Completion
2011-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01600196 on ClinicalTrials.gov